drug
THRV-1268
Phase 3updated 3mo agoby $THRY Thryv Holdings, Inc.
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying THRV-1268
- phase3Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)
- phase1Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, PK, PD, and Comparative Bioavailability of THRV-1268 in Obese Adult Participants
- phase1Study to Assess the Safety, Tolerability, Pharmacokinetic of Thrv-1268
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that